Study suggests psychotherapy beneficial for post-surgical pain

The researchers found that cognitive behavioural therapy or relaxation therapy, on average, reduced ongoing pain and physical impairment by 10 per cent, but education had no effect.

By Tina Depko, Health Sciences July 18, 2018

Jason Busse, Health Sciences, McMaster Health Sciences, McMaster Jason Busse
Jason Busse is an associate professor of anesthesia at McMaster University.

Expert Featured In This Story

Jason Walter Busse
Jason Walter Busse

Professor

See Profile

Psychotherapy for surgical patients is effective for reducing persistent pain and physical impairment, while simply providing education has no effect, suggests a study led by McMaster University researchers.

Persistent post-surgical pain affects between 10 to 80 per cent of patients after common operations. In addition, surgical patients with psychological factors such as depression or anxiety are more likely to develop chronic pain.

The researchers found that cognitive behavioural therapy or relaxation therapy, on average, reduced ongoing pain and physical impairment by 10 per cent, but education had no effect.

They conducted an analysis of pre-existing trial data to better understand the impact of psychotherapy on post-operative outcomes when administered before or after surgery. Their results were published in the British Journal of Anaesthesia.

“This is the first review that explores perioperative psychotherapy for persistent post-surgical pain and function,” said Jason Busse, senior author of the study and an associate professor of anesthesia at McMaster. He is also a researcher for the Michael G. DeGroote Institute for Pain Research and Care.

“Our results suggest that providing information and support alone for surgical patients is not sufficient and that more active psychotherapy is needed to improve long-term outcomes.”

Researchers searched through five electronic databases up to Sept. 1, 2016. They found 15 trials with a total of 2,220 adult patients eligible for review. The trials enrolled patients undergoing orthopedic surgery, coronary artery bypass graft, or colonic and colorectal surgery.

Studies eligible for their review compared any perioperative psychological intervention against usual care, and explicitly reported data on persistent post-surgical pain or physical impairment from three to 12 months after surgery.

“Persistent post-surgical pain is associated with reduced quality of life, physical and psychological impairment, increased health care costs, and accounts for a substantial portion of chronic pain in general,” said Busse. “Our meta-analysis suggests long-term benefits of perioperative psychological intervention for patients undergoing surgical procedures.”

Researchers recommended that future studies should explore targeted psychotherapy for surgical patients at higher risk for poor outcomes.

Additional researchers on the study came from McMaster, University of Toronto, University of Ottawa, and St. Joseph’s Healthcare Hamilton. The study required no external funding.

Read the study here.

A close-up of a vial containing a clear peptide blend of BPC-157 and TB-500, next to two single-use syringes.

What do we know about ‘research only’ peptides? Q&A with expert Stuart Phillips 

Unapproved peptides that lack safety and efficacy data carry substantial risks and belong in a laboratory, not your body, Phillips warns.
Scientist Jon Stokes stands in a university corridor, wearing a hoodie and ball cap.

McMaster researcher awarded more than $2M from Weston Family Foundation to advance precision antibiotic for IBD

The funding will accelerate the move toward human trials, enabling preclinical studies, regulatory preparation and early-phase clinical trial design.
?A stent being held by a clinician wearing gloves.

Minimally invasive procedure offers new hope for patients with complications from blood clots

Patients who had the procedure experienced a significantly better quality of life and less severe post-thrombotic syndrome, a painful condition that affects 20 to 50 per cent of people who had a deep vein thrombosis.